Tekturna (Novartis Pharmaceuticals Corporation)


Welcome to the PulseAid listing for the Tekturna drug offered from Novartis Pharmaceuticals Corporation. This Renin Inhibitor [EPC],Renin Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Novartis Pharmaceuticals Corporation
NON-PROPRIETARY NAME: aliskiren hemifumarate
SUBSTANCE NAME: ALISKIREN HEMIFUMARATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Renin Inhibitor [EPC],Renin Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2007-03-05
END MARKETING DATE: 0000-00-00


Tekturna HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTekturna from Novartis Pharmaceuticals Corporation
LABELER NAME: Novartis Pharmaceuticals Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 150(mg/1)
START MARKETING DATE: 2007-03-05
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0078-0485_7728a56e-1ef0-48cd-bef7-ff51198e4e63
PRODUCT NDC: 0078-0485
APPLICATION NUMBER: NDA021985

Other ALISKIREN HEMIFUMARATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalTekturna
Noden Pharma USA, Inc.Tekturna
Novartis Pharmaceuticals CorporationTekturna
Physicians Total Care, Inc.Tekturna